VGHCX Mutual Fund Price & Analysis

For more than 25 years, this actively managed fund has offered investors low-cost exposure to domestic and foreign companies involved in various aspects of the health care industry, such as pharmaceutical firms, medical supply companies, and research firms. The fund tends to be more geographically diverse and exhibit lower turnover than other health care funds. Still, one risk to note is the fund’s narrow scope, investing solely within the health care sector. Returns may vary widely from year to year, so this fund should be considered complementary to a diversified portfolio with a long-term time horizon.

VGHCX Mutual Fund Chart & Stats

$195.67

-$0.86(-0.44%)

Apr 15, 2026

―

VGHCX Mutual Fund News

PremiumMarket News

FSHCX and VGHCX: 2 Healthcare Funds with Upside Potential, According to Analysts

2y ago

PremiumStock Analysis & Ideas

2 Healthcare Mutual Funds with Upside Potential, According to Analysts

2y ago

PremiumMarket News

Analysts Applaud as Eli Lilly’s (LLY) Obesity Pill Is Found to Help Prevent Heart Attacks

6h ago

LLY

PremiumThe Fly

Abbott organic outlook cut, says Wolfe Research

6h ago

ABT

VGHCX Mutual Fund Smart Score

Neutral

Analyst Consensus

Moderate Buy

Average Price Target:
241.36 (― Downside)

Learn more about TipRanks Smart Score

For Mutual Funds, the calculations for the Smart Score, Analyst Consensus, Price Target, Blogger Sentiment, News Sentiment and Insider Transactions are based on the weighted average of the Mutual Fund's holdings and some additional factors. Hedge Fund Trend, Crowd Wisdom and Technicals are based on the actual Mutual Fund ticker.